ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 103 filers reported holding ALLAKOS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $18 | +500.0% | 4,203 | +794.3% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 470 | -99.4% | 0.00% | -100.0% |
| Q3 2022 | $507,000 | +79.2% | 82,896 | -8.5% | 0.00% | – |
| Q2 2022 | $283,000 | +3437.5% | 90,606 | +5700.6% | 0.00% | – |
| Q1 2022 | $8,000 | -94.8% | 1,562 | -90.1% | 0.00% | – |
| Q4 2021 | $154,000 | -38.2% | 15,815 | +453.9% | 0.00% | – |
| Q3 2021 | $249,000 | +10.2% | 2,855 | +7.5% | 0.00% | – |
| Q2 2021 | $226,000 | -58.2% | 2,655 | -43.7% | 0.00% | -100.0% |
| Q1 2021 | $541,000 | +2476.2% | 4,715 | +1659.3% | 0.00% | – |
| Q3 2020 | $21,000 | -27.6% | 268 | -34.3% | 0.00% | – |
| Q2 2020 | $29,000 | +7.4% | 408 | -34.2% | 0.00% | – |
| Q1 2020 | $27,000 | 0.0% | 620 | +75.1% | 0.00% | – |
| Q3 2019 | $27,000 | – | 354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |